Shawn M. Carter is the Deputy Editor for Forbes Health, focusing on healthcare and medical topics. With a background in journalism and previous experience at CNBC and Fox Business, Shawn's work has appeared in various publications, including Forbes, CNBC, and Acorns. He is particularly interested in covering stories related to dialysis, kidney health, and transplantation.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Shawn M. Carter's articles primarily focus on nephrology, kidney health, dialysis, transplantation, and kidney disease. The coverage attributes indicate a heavy reliance on data citations (98%) with themes covering scientific research (55%) and healthcare & pharmaceuticals (29%).
If you are considering reaching out to Shawn M. Carter with a pitch or contribution related to the topics covered in his articles, it would be beneficial to offer fact-based insights supported by credible data within the field of nephrology. Additionally, providing information about recent studies or developments in the areas of kidney health, dialysis, transplantation or kidney disease is likely to align well with his coverage interests.
Given that there is no specific geographic focus indicated for this journalist's work, pitches should emphasize globally relevant trends and findings within nephrology and related fields.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Gina Brockenbrough, Shawn M. Carter
In a study using U.S. Military Health System data, adoption of the 2021 Chronic Kidney Disease Epidemiology Collaboration equation that removes a race coefficient to determine eGFR may reclassify Black adults into more advanced CKD stages.
By: Gina Brockenbrough, Shawn M. Carter
Financial incentives offered to providers in a CMS payment model have failed to increase home dialysis and kidney transplantation rates in the first 2 years of the demonstration, published findings show.
By: Gina Brockenbrough, Shawn M. Carter
Key takeaways: Patients of racialized immigrant status were less likely to discuss living donor kidney transplant.
By: Shawn M. Carter, Mindy Valcarcel
Key takeaways: The future of the nephology field leans on collaboration between stakeholders. Innovation in kidney care may be boosted by rethinking approaches.
By: Shawn M. Carter, Gina Brockenbrough
Dietary patterns may vary significantly in patients with different stages of chronic kidney disease, according to an investigation of food group intake among patients in a United Kingdom study.
By: Shawn M. Carter, Gina Brockenbrough
The frequency and risk of AKI in patients hospitalized with inflammatory bowel disease is higher compared with admissions with collagen vascular diseases and from the general population, a recently published study shows.
By: Gina Brockenbrough, Shawn M. Carter
A text message-based survey was highly acceptable and had moderate reach for patients on dialysis, according to published data, though response rates were lower in certain groups.
By: Gina Brockenbrough, Shawn M. Carter
Researchers have identified two loci that may be associated to AKI in hospitalized patients with kidney disease, noting a potential genetic risk of the condition, data show.
By: Gina Brockenbrough, Shawn M. Carter
Patients with end-stage kidney disease may be at higher risk for hypoglycemia, with a disproportionate effect on young, Black and female patients, according to published data.
By: Shawn M. Carter, Gina Brockenbrough
Incident cardiovascular and thromboembolic events may be more closely linked to the severity of kidney disease than with glomerular disease subtype, according to results of a prospective study.
(833) 317-6278 
